1 active not recruiting, 1 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Active not recruiting 1 |
Follow Anne Noonan: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dasatinib for the Prevention of Oxaliplatin-Induced Neuropathy in Patients With Metastatic Gastrointestinal Cancer Receiving FOLFOX Chemotherapy With or Without Bevacizumab Bevacizumab, Dasatinib, Fluorouracil - Advanced Colorectal Carcinoma, Metastatic Colorectal Carcinoma | Phase 1 | Completed | Anne Noonan | 9 | 2020-09-02 | 2024-12-27 |
| Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer Gemcitabine, Nab-paclitaxel - Metastatic Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 | Phase 2 | Active not recruiting | Anne Noonan | 67 | 2020-06-24 | 2026-08-12 |
Pancreatic Neoplasms (2) · Bile Duct Neoplasms (1) · Colonic Neoplasms (1) · Colorectal Neoplasms (1) · Esophageal Neoplasms (1) · Gallbladder Neoplasms (1) · Rectal Neoplasms (1) · Stomach Neoplasms (1)
130-nm albumin-bound paclitaxel (1) · Albumin-Bound Paclitaxel (1) · Bevacizumab (1) · Dasatinib (1) · Disulfides (1) · Fluorouracil (1) · Gemcitabine (1) · Immunoglobulin G (1) · Leucovorin (1) · Oxaliplatin (1) · Taxes (1) · dehydroftorafur (1)
United States (2)
Anne M Noonan, MBBChBAO, MSc (1) · Laith Abushahin, MBBS (1)